A review of the clinical evidence for intensity-modulated radiotherapy
J Staffurth - Clinical oncology, 2010 - Elsevier
AIMS: Intensity-modulated radiotherapy (IMRT) is a development of three-dimensional
conformal radiotherapy that offers improvements in dosimetry in many clinical scenarios …
conformal radiotherapy that offers improvements in dosimetry in many clinical scenarios …
Dose–volume effects for normal tissues in external radiotherapy: pelvis
C Fiorino, R Valdagni, T Rancati… - Radiotherapy and …, 2009 - Elsevier
A great deal of quantitative information regarding the dose–volume relationships of pelvic
organs at risk has been collected and analysed over the last 10 years. The need to improve …
organs at risk has been collected and analysed over the last 10 years. The need to improve …
Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective …
Purpose To evaluate the toxicity and clinical outcome in patients with locally advanced
cervical cancer (LACC) treated with whole pelvic conventional radiation therapy (WP-CRT) …
cervical cancer (LACC) treated with whole pelvic conventional radiation therapy (WP-CRT) …
Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical …
W Small Jr, LK Mell, P Anderson, C Creutzberg… - International Journal of …, 2008 - Elsevier
PURPOSE: To develop an atlas of the clinical target volume (CTV) definitions for
postoperative radiotherapy of endometrial and cervical cancer to be used for planning pelvic …
postoperative radiotherapy of endometrial and cervical cancer to be used for planning pelvic …
Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy
Purpose: To identify dosimetric parameters associated with acute hematologic toxicity (HT)
and chemotherapy delivery in cervical cancer patients undergoing concurrent chemotherapy …
and chemotherapy delivery in cervical cancer patients undergoing concurrent chemotherapy …
Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity …
PURPOSE: To test the hypothesis that the volume of pelvic bone marrow (PBM) receiving 10
and 20 Gy or more (PBM-V10 and PBM-V20) is associated with acute hematologic toxicity …
and 20 Gy or more (PBM-V10 and PBM-V20) is associated with acute hematologic toxicity …
Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose–positron emission tomography simulation in patients with locally …
EA Kidd, BA Siegel, F Dehdashti, JS Rader… - International Journal of …, 2010 - Elsevier
PURPOSE: This study aimed to evaluate the toxicity and clinical outcomes for cervical
cancer patients treated definitively with intensity-modulated radiation therapy (IMRT) …
cancer patients treated definitively with intensity-modulated radiation therapy (IMRT) …
Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer
PURPOSE: To compare bone marrow-sparing intensity-modulated pelvic radiotherapy (BMS-
IMRT) with conventional (four-field box and anteroposterior–posteroanterior [AP–PA]) …
IMRT) with conventional (four-field box and anteroposterior–posteroanterior [AP–PA]) …
Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow–sparing pelvic IMRT
K Albuquerque, D Giangreco, C Morrison… - International Journal of …, 2011 - Elsevier
PURPOSE: To determine factors predictive for hematologic toxicity (HT) associated with
concurrent chemoradiation for Stage II through IV cervical cancer. METHODS AND …
concurrent chemoradiation for Stage II through IV cervical cancer. METHODS AND …
Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome
Purpose: To assess survival, local control, and toxicity of intensity modulated radiation
therapy (IMRT) in squamous cell carcinoma of the anal canal. Methods and Materials …
therapy (IMRT) in squamous cell carcinoma of the anal canal. Methods and Materials …